Aditya S. Pandey, Md

This Phase 2 trial tests whether deferoxamine, a drug that binds excess iron, can reduce brain injury after aneurysmal subarachnoid hemorrhage (aSAH), a severe stroke with high death and disability rates. About 120 participants will receive one of two doses of deferoxamine or a p…